Abstract
The paper presents the results of a follow-up and treatment of 30 patients with arterial hypertension (AH) accompanied by the persistent blood pressure elevation that requires continuous antihypertensive therapy and that is associated with type 2 diabetes mellitus. It shows the antihypersensive effect of the imidazoline-receptor agonist moxonidine and its positive action on metabolic parameters and a risk for cardiovascular events in this group of patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: "Arterial’naya Gipertenziya" ("Arterial Hypertension")
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
